BDRX
Biodexa Pharmaceuticals
BDRX
BDRX
hedge funds and large institutions have $81K invested in Biodexa Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
–
Holders Change %
–
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
IG
ING Group
Amsterdam,
Netherlands
|
-$85K |
| 2 |
Morgan Stanley
New York
|
-$72K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
-$29K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$23K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $23K | – | – | – |
|
|
CL
2
CSS LLC
Chicago,
Illinois
| $23K | -$29K | – | – |
|
|
3
Verition Fund Management
Greenwich,
Connecticut
| $20K | -$23K | – | – |
|
|
4
Morgan Stanley
New York
| $15K | -$72K | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$3K | – | – |
|
|
IG
6
ING Group
Amsterdam,
Netherlands
| – | -$85K | – | – |
|